Request for Information: Strategies to Develop a Single-Dose Vaccine for Pandemic Influenza

The Division of Research, Innovation and Ventures (DRIVe) of the Biomedical Advanced Research and Development Authority (BARDA), the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) is issuing this Request for Information (RFI) to solicit feedback from biopharmaceutical stakeholders and other vaccine development experts regarding strategies to develop a pandemic influenza vaccine that elicits robust and durable immunity following a single dose in humans. To view the full RFI, including the specific questions for which BARDA is seeking answers, please see the attached document.